[1] Navas LE, Carnero A. NAD+ metabolism, stemness, the immune response, and cancer. Signal Transduct Target Ther. 2021 Jan 1;6(1):2. doi: 10.1038/s41392-020-00354-w. PMID: 33384409; PMCID: PMC7775471.
[2]Berven, H., Kverneng, S., Sheard, E. et al. NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease. Nat Commun 14, 7793 (2023). https://doi.org/10.1038/s41467-023-43514-6
[3]Blanco-Vaca Francisco , Rotllan Noemi , Canyelles Marina , Mauricio Didac , Escolà-Gil Joan Carles , Julve Josep. NAD+-Increasing Strategies to Improve Cardiometabolic Health?. Frontiers in Endocrinology 12(2022). https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.815565
[4] Martens, C.R., Denman, B.A., Mazzo, M.R. et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun 9, 1286 (2018). https://doi.org/10.1038/s41467-018-03421-7
[5] Soma M, Lalam SK. The role of nicotinamide mononucleotide (NMN) in anti-aging, longevity, and its potential for treating chronic conditions. Mol Biol Rep. 2022 Oct;49(10):9737-9748. doi: 10.1007/s11033-022-07459-1. Epub 2022 Apr 20. PMID: 35441939.